Minimizing Blood Loss in Laparotomic Myomectomy through the Tourniquet Use: Insights from Our Clinical Experience and Literature Review
-
Published:2024-03-29
Issue:2
Volume:5
Page:162-171
-
ISSN:2673-4095
-
Container-title:Surgeries
-
language:en
-
Short-container-title:Surgeries
Author:
Incognito Giosuè Giordano1ORCID, Gulino Ferdinando Antonio2ORCID, Cianci Stefano2ORCID, Occhipinti Sara1ORCID, Incognito Dalila3, De Tommasi Orazio4ORCID, Genovese Fortunato1, Palumbo Marco1
Affiliation:
1. Department of General Surgery and Medical Surgical Specialties, University of Catania, 95123 Catania, Italy 2. Unit of Gynecology and Obstetrics, Department of Human Pathology of Adults and Developmental Age, “G. Martino” University Hospital, 98122 Messina, Italy 3. Medical Oncology Unit, Department of Human Pathology “G. Barresi”, University of Messina, 98122 Messina, Italy 4. Department of Women and Children’s Health, Clinic of Gynecology and Obstetrics, University of Padua, 35100 Padua, Italy
Abstract
The uterine tourniquet is often not used to reduce intraoperative blood loss due to controversial opinions in the literature. The objective was to evaluate the effectiveness of this procedure in laparotomic myomectomy. This is a retrospective, monocentric case-control study, including patients who underwent laparotomic myomectomy and were categorized into the Tourniquet Group (A) and No Tourniquet Group (B). The blood loss outcomes were compared. Intra-operative blood loss in Group A was 275 ± 200 mL, while in Group B was 410 ± 390 mL (p = 0.11). Notably, five patients in the No Tourniquet Group lost more than 1000 mL of blood and required blood transfusion, while no such cases were reported in the Tourniquet Group. Furthermore, the decrease in hemoglobin post-procedure was statistically significant, favoring Group A with a decrease of 1.9 ± 0.7 g/dL compared to Group B’s 2.8 ± 2.2 g/dL (p = 0.04). The use of the Foley catheter as a tourniquet during laparotomic myomectomy may represent a remarkable tool that profoundly impacts the surgical process by substantially reducing blood loss. Its use may play a role in significantly diminishing the likelihood of requiring blood transfusions, enhancing patient safety and outcomes, and should be systematically adopted.
Reference39 articles.
1. Uterine fibroid: A review;Akinyemi;Niger. J. Med. J. Natl. Assoc. Resid. Dr. Niger.,2004 2. The Effect of a Myomectomy on Myoma-related Symptoms and Quality of Life: A Retrospective Cohort Study;Don;J. Minim. Invasive Gynecol.,2023 3. Cianci, S., Gulino, F.A., Palmara, V., La Verde, M., Ronsini, C., Romeo, P., Occhipinti, S., Incognito, G.G., Capozzi, V.A., and Restaino, S. (2023). Exploring Surgical Strategies for Uterine Fibroid Treatment: A Comprehensive Review of Literature on Open and Minimally Invasive Approaches. Medicina, 60. 4. D’urso, V., Gulino, F.A., Incognito, G.G., Cimino, M., Dilisi, V., Di Stefano, A., Gulisano, M., Cannone, F., Capriglione, S., and Palumbo, M. (2023). Hysteroscopic Findings and Operative Treatment: All at Once?. J. Clin. Med., 12. 5. Pitter, M.C., Simmonds, C., Seshadri-Kreaden, U., and Hubert, H.B. (2014). The Impact of Different Surgical Modalities for Hysterectomy on Satisfaction and Patient Reported Outcomes. Interact. J. Med. Res., 3.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|